Aphelion Capital
Venture capitalSeed–Late Stage · 11 people tracked
Investment thesis
Aphelion Capital invests in early and mid-stage medical device and digital health companies whose products and services are capital efficient and improve patient outcomes while keeping costs the same or lower for the healthcare system. The firm looks for passionate leaders committed to solving current healthcare problems and leverages a network of strategic relationships to give portfolio companies the resources and support they need to succeed within the healthcare ecosystem.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from the firm's website & public directories
.png)
What they invest in
from 21 of 24 portfolio companiesMedical Devices ×18Healthtech ×17Digital Health ×7Hardware ×5Biotech ×3AI & Machine Learning ×1Cloud Computing ×1Direct to Consumer ×1
HQs:United States×12
Investments · 24 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12020 · 24 dated
SeaStar Medical develops the Selective Cytopheretic Device (SCD), a therapy that targets highly activated neutrophils and monocytes to neutralize the hyperinflammatory immune response in critically ill ICU patients facing conditions such as infection, trauma, or surgery.
BiotechHealthtechMedical DevicesDenver, US
Eric Schlorff(Executive Officer, Director)inAlvin Vitangcol(Director)Kenneth Van Heel(Director)Leslie Bottorff(Director)William White(Director)H David Humes(Director)
Co-investorsCapital Midwest FundEarly Stage Partners, LPWMU Biosciences Research & Commercialization Center
Airlift offers a minimally invasive surgical procedure for treating sleep apnea and snoring by lifting and securing the hyoid bone to support the airway, performed in outpatient settings.
Medical Devices
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Co-investorsAPERTURE Venture PartnersAscension VenturesLumira VenturesRex Health VenturesSV Health InvestorsAscension+1 more
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.
Digital HealthHardwareMedical Devices
Jared Tangney(Founder)inRich Yangin
Co-investorsAble PartnersAlpha Wave GlobalAverin CapitalBOLD LongevityHikma VenturesM Ventures+2 more
ClearFlow develops PleuraFlow Active Clearance Technology, a device that maintains chest drain patency after cardiac surgery to reduce Retained Blood Syndrome complications, along with products for sternal fixation and reconstruction following sternotomy.
HardwareHealthtechMedical DevicesIrvine, US
Edward M. Boyle(Director)Paul Molloy(Executive Officer, Director)Hannah Beathard(Executive Officer)Andrew Firlik(Director)Alex Suh(Director)Andrew D Firlik(Director)
Co-investorsCalifornia Technology VenturesOregon Venture Fund
CoLabs Medical is developing The Ventor, an emergency airway and ventilation system intended to improve airway management and ventilation during cardiac arrest.
HardwareHealthtechMedical Devices
Co-investorsHealthtech CapitalSeraph Group
Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAngel Physicians FundBlueStone Venture Partners
Freespira is a medication-free treatment device that uses breathing regulation training to address panic attacks and PTSD symptoms.
Digital HealthMedical DevicesMental Health
Co-investorsLightspeed Venture PartnersMedvest Capital
Co-investorsForepont Capital Partners
Koya Medical develops wearable compression therapy devices, including its Dayspring system, for treating conditions such as lymphedema, chronic venous insufficiency, and deep vein thrombosis.
HardwareHealthtechMedical DevicesOakland, US
Anand Doraiswamy(Executive Officer, Director)
BoardJosh Baltzell(Director)inJan Garfinkle(Director)in
Co-investorsArboretum VenturesScientific Health DevelopmentZühlke VenturesOrbiMed
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsgener8torShangBay Capital LLC
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature.
BiotechHealthtechMedical DevicesSan Leandro, US
Trent Reutiman(Executive Officer, Director)Stephen Baker(Executive Officer)Kirk Seward(Executive Officer)Charles Crocker(Director)Doug Wall(Director)Kirk P. Seward(Co-founder, President and CEO)
Co-investorsMedvest Capital
Motive Health (formerly CyMedica Orthopedics) offers an at-home muscle strengthening therapy for knee pain relief, sold directly online to consumers without a prescription.
Digital HealthDirect to ConsumerMedical Devices
Co-investorsCalifornia Technology Ventures
Movn Health is a healthcare company focused on improving access to cardiovascular care, working to improve health outcomes, care coordination, patient engagement, and retention.
Digital HealthHealthtechLos Angeles, US
Harshvardhan Vathsangam(Executive Officer, Director)Ade Adesanya(Director)in
BoardBob Saunders(Director)John Kim(Director)Eric Marton(Director)inAdrian James(Director)
Co-investorsFoothill VenturesSolve VenturesSteelSky VenturesSeae VenturesWavemaker Three-Sixty Health
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field.
BiotechHealthtechMedical DevicesDover, US
John Springer(Executive Officer, Director)Bruce Roberts(Director)
Co-investorsCorewell Health Ventures
NeurOptics manufactures the NPi-300 pupillometer, a handheld medical device that measures pupil size and reactivity for critical care assessment in hospitals.
HealthtechMedical DevicesIrvine, US
Kamran Siminou(Executive Officer, Director)William Worthen(Executive Officer, Director)Joseph Kiani(Director)Willam Worthen(Executive Officer, Director)
BoardBob Mellen(Director)
Orpyx develops a wearable system with smart footbeds, a receiver, and hub that provides real-time plantar pressure monitoring and alerts to help individuals with impaired protective sensation prevent foot ulcers and complications.
HealthtechIoTMedical Devices
Co-investorsNext VenturesThin Air Labs
Phagenesis develops the Phagenyx System, a medical device that uses pharyngeal electrical stimulation to restore swallowing control in stroke patients with dysphagia, reducing hospital stays and aspiration risk.
Digital HealthHealthtechMedical Devices
Co-investorsInnvotec Ltd.Northern Gritstone
Co-investorsMedvest Capital
Spencer Health Solutions makes spencer®, a smart medication dispenser and data platform that automates dispensing, sends reminders, and collects real-time adherence data.
Digital HealthHardwareHealthtechMorrisville, US
Thomas P. Rhoads, Jr.(Executive Officer, Director)Paul Cunningham(Executive Officer)
BoardChristopher Martin(Director)Gregg Goldenberg(Director)Mark Gilreath(Director)Edwin Scheetz(Director)
Co-investorsCalifornia Technology Ventures
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)in
BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in
Co-investorsShangBay Capital LLC
Co-investorsCorewell Health VenturesGenerator Ventures
Wesper offers an FDA-cleared, patch-based home sleep testing ecosystem with two diagnostic tiers plus interpretation and RPM services.
HealthtechNew York, US
Amir Reuveny(Executive Officer)
BoardSanto Politi(Director)in
Co-investorsAbstract VenturesKrillion VenturesSpark Capital
Zeto develops a cloud-based EEG (electroencephalogram) system for rapid neurological diagnosis in hospitals, emergency departments, outpatient clinics, and research settings.
Cloud ComputingHealthtechMedical Devices
Co-investorsIaso Ventures
Exits · 1
IPOs and acquisitions across the tracked portfolioSeaStar MedicalNASDAQ: ICU
Portfolio news
latest coverage across their companiesSeaStar Medical · manilatimes.net · Aug 12, 2026
Wesper · intelligence360.news · Aug 10, 2026
Koya Medical · briefglance.com · May 26, 2026
Biolinq · fiercebiotech.com · Sep 29, 2025
Motive · techfundingnews.com · Aug 4, 2025
Frequently asked questions
- How many investments has Aphelion Capital made?
- Aphelion Capital has 24 tracked investments.
- What stage does Aphelion Capital invest at?
- Aphelion Capital invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does Aphelion Capital focus on?
- Aphelion Capital focuses on Digital Health, Healthtech, Medical Devices.
- Who does Aphelion Capital co-invest with?
- Aphelion Capital most often shares deals with California Technology Ventures, Medvest Capital, Corewell Health Ventures, among 41 tracked co-investors.
Images
Co-investors · 6
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
FirstMark is a venture capital firm that backs founders and supports them through a platform providing access to networks, customers, and talent.
Fifth Wall is an investment firm focused on technology for the built environment (PropTech), backing startups that make the spaces where people live, work, and play smarter, safer, and more energy efficient.
Flare Capital Partners is a healthcare technology-focused venture firm that partners with founders building companies to improve outcomes, lower costs, and reshape healthcare delivery.
OCA Ventures is a venture capital firm that partners with founders from seed stage onward, providing capital along with strategic advice and introductions across sectors including biotech, healthcare, and technology.
Okapi Venture Capital is a seed and early-stage venture capital firm focused on information technology and life science investments, which closed its first fund in May 2006.
Firms observed investing alongside Aphelion Capital, from public investor directories. Shared companies are the overlap with Aphelion Capital's recorded portfolio.
Similar investors
Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.
Ascension Ventures manages capital and presents itself as an investor connected to a large health system network, referencing hundreds of acute care hospitals and a substantial employee base.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
CareQuest Innovation Partners drives innovation in oral and integrated health through impact investing, innovation programs, and corporate partnerships aimed at improving accessibility, equity, and the integration of oral health with overall health.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.